ACETAMINOPHEN AND PHENYLTOLOXAMI. Key specifications include primary_container_type: BOTTLE, primary_container_content_quantity: 1000.000 TABLETS, active_medicament_medicinal_strength: 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS PHENYLTOLOXAMINE CITRATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ACETAMINOPHEN AND PHENYLTOLOXAMINE CITRATE TABLETS 1000S BT. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-155-0515, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 1000.000 TABLETS |
| active_medicament_medicinal_strength | 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS PHENYLTOLOXAMINE CITRATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ACETAMINOPHEN AND PHENYLTOLOXAMINE CITRATE TABLETS 1000S BT |
| NSN | 6505-01-155-0515 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS PHENYLTOLOXAMINE CITRATE ACTIVE INGREDIENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ACETAMINOPHEN AND PHENYLTOLOXAMINE CITRATE TABLETS 1000S BT |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |